Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients

OBJECTIVE: Relapsed and refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) are the focus of studies on hematological cancers. Treatment of these malignancies has undergone recent transformation with the development of new gene therapy and molecular biol...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Turk J Haematol
Huvudupphovsmän: Taştan, Cihan, Kançağı, Derya Dilek, Turan, Raife Dilek, Yurtsever, Bulut, Çakırsoy, Didem, Abanuz, Selen, Yılancı, Muhammet, Seyis, Utku, Özer, Samed, Mert, Selin, Kayhan, Cavit Kerem, Tokat, Fatma, Açıkel Elmas, Merve, Birdoğan, Selçuk, Arbak, Serap, Yalçın, Koray, Sezgin, Aslıhan, Kızılkılıç, Ebru, Hemşinlioğlu, Cansu, İnce, Ümit, Ratip, Siret, Ovalı, Ercüment
Materialtyp: Artigo
Språk:Inglês
Publicerad: Galenos Publishing 2020
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7702660/
https://ncbi.nlm.nih.gov/pubmed/32755128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.galenos.2020.2020.0070
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk